Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Andrew Darlington"'
Autor:
Joseph Andrew Darlington
Publikováno v:
Journal of European Studies. 53:5-22
This article explores the influence of John Berger on Eva Figes’ novel Light (1981). The novel describes a day in the life of Claude Monet. Figes’ depiction of Monet’s artistic processes reflects her own explorations of literary-critical theory
Autor:
Lucy A. Snyder, Adrian Cole, Franklyn Searight, Andrew Darlington, D.C. Lozar, Erica Ruppert, John Linwood Grant, Scott Edelman, Doug Draa
Every year, WEIRDBOOK Magazine publishes a collection of short stories to thrill and delight readers worldwide. This year, we challenged authors to come up with memorable takes on the zombie theme, and the result is this fantastic collection of 34 or
Autor:
Steven R. Sigman, Andrew Darlington, Benjamin DeMoss, Arun Krishnamoorthy, Rabah Alreshq, Catherine N. Marti, Frederick L. Ruberg
Publikováno v:
Journal of the American College of Cardiology. 77:1353
Autor:
Antonio Tello-Montoliu, Francesco Franchi, Masafumi Ueno, Theodore A. Bass, Joseph A. Jakubowski, Dominick J. Angiolillo, Atsuhiro Sugidachi, Luis A. Guzman, Brian A. Moser, Andrew Darlington, Bhaloo Desai, Fabiana Rollini, José Luis Ferreiro
Publikováno v:
Journal of the American College of Cardiology. 64:1005-1014
Background Several studies have shown that patients with diabetes mellitus (DM) exhibit an impaired response to clopidogrel. This may contribute to their increased risk of recurrent atherothrombotic events, despite the use of dual-antiplatelet therap
Autor:
Jung Rae Cho, Francesco Franchi, Fabiana Rollini, Martin M. Zenni, Ronakkumar Patel, Antonio Tello-Montoliu, Dominick J. Angiolillo, Jose-Luis Ferreiro, Bhaloo Desai, Luis A. Guzman, Theodore A. Bass, Andrew Darlington, Ana Muniz-Lozano, Elisabetta Ferrante, Mona Bhatti, Christopher DeGroat
Publikováno v:
Journal of Cardiovascular Translational Research. 7:53-63
Smokers have a greater relative benefit of clopidogrel therapy compared with nonsmokers, likely attributed to its enhanced pharmacodynamic (PD) effects. However, to date, all PD studies have been conducted in patients on dual antiplatelet therapy wit
Autor:
Bhaloo Desai, Ana Muniz-Lozano, Andrew Darlington, Norbert Bender, Ryan E. Wilson, Kjell S. Sakariassen, Ronakkumar Patel, Fabiana Rollini, Francesco Franchi, Dominick J. Angiolillo, Antonio Tello-Montoliu
Publikováno v:
Journal of Thrombosis and Thrombolysis. 37:131-138
Patients with diabetes mellitus (DM) have increased propensity to generate thromboxane A2 (TXA2) and other eicosanoids which can contribute to their heightened platelet reactivity. EV-077 is a potent thromboxane receptor antagonist and thromboxane sy
Autor:
Ana Muniz-Lozano, Francesco Franchi, Andrew Darlington, Luis A. Guzman, Fabiana Rollini, Bhaloo Desai, Dominick J. Angiolillo, Estela Thano, Ryan E. Wilson, Theodore A. Bass, Ronakkumar Patel, Antonio Tello-Montoliu
Publikováno v:
Thrombosis and Haemostasis. 110:777-784
SummaryDifferent aspirin dosing regimens have been suggested to impact outcomes when used in combination with adenosine diphosphate (ADP) P2Y12 receptor antagonists. Prior investigations have shown that not only aspirin, but also potent ADP P2Y12 rec
Autor:
Antonio Tello-Montoliu, Masafumi Ueno, Andrew Darlington, Davide Capodanno, Fabiana Rollini, Luis A. Guzman, Murali Kodali, Dominick J. Angiolillo, Bhaloo Desai, Theodore A. Bass, Ronakkumar Patel, José Luis Ferreiro, Salvatore D. Tomasello
Publikováno v:
Journal of Thrombosis and Thrombolysis. 36:14-17
Diabetes mellitus (DM) is the most important predictor of chronic kidney disease (CKD), and pharmacodynamic (PD) studies have shown that DM patients with impaired renal function are characterized by reduced clopidogrel response. However, post-hoc PD
Autor:
Bhaloo Desai, Antonio Tello-Montoliu, Dominick J. Angiolillo, Kodlipet Dharmashankar, Piera Capranzano, Fabiana Rollini, Masafumi Ueno, Andrew Darlington, José Luis Ferreiro, Davide Capodanno
Publikováno v:
Catheterization and Cardiovascular Interventions. 81:42-49
Background In patients on dual antiplatelet therapy with aspirin and clopidogrel, the adjunctive use of cilostazol is associated with enhanced platelet inhibition. However, if cilostazol exerts different pharmacodynamic (PD) effects according to leve
Autor:
Davide Capodanno, Sabrina Sumner, Piera Capranzano, Bhaloo Desai, Masafumi Ueno, Kodlipet Dharmashankar, Luis A. Guzman, Lyndon C. Box, Theodore A. Bass, Martin M. Zenni, Ronald K. Charlton, José Luis Ferreiro, Andrew Darlington, Dominick J. Angiolillo
Publikováno v:
Thrombosis and Haemostasis. 106:253-262
SummaryCilostazol is a platelet inhibitor which when added to aspirin and clopidogrel has shown to reduce the risk of recurrent ischaemic events without an increase in bleeding. These clinical benefits have shown to be more pronounced in patients wit